SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain

Abstract

Background Esophageal squamous cell carcinoma (ESCC) remains one of the most lethal cancers worldwide accompany with an extremely poor prognosis. Therefore, this study aims to screen for new molecules affecting ESCC and explore their mechanisms of action to provide ideas for targeted therapies for ESCC. Methods Firstly, we screened out the membrane protein SCARA5 by high-throughput sequencing of the ESCC patient tissues, and RT-qPCR and WB were used to verify the differential expression of SCARA5 in esophageal cell lines, and IHC analyzed the expression localization of SCARA5 in ESCC tissue. Then, flow cytometry, wound healing assay, Transwell assay and CCK-8 assay were used to explore the effects of SCARA5 on cell cycle, migration and invasion as well as cell proliferation activity of esophageal squamous carcinoma cells. Meanwhile, transmission electron microscopy was used to detect changes in cellular mitochondrial morphology, and flow cytometry were used to detect changes in intracellular reactive oxygen metabolism, and immunofluorescence and flow cytometry were used to detect changes in intracellular Fe2+. Mechanistically, co-immunoprecipitation was used to detect whether SCARA5 binds to ferritin light chain, and ferroptosis-related protein expression was detected by WB. Finally, the tumor xenograft model was applied to validation the role of SCARA5 tumor growth inhibition in vivo. Results We found that SCARA5 was aberrantly decreased in ESCC tissues and cell lines. Furthermore, we confirmed that SCARA5 suppressed the cell cycle, metastasis and invasion of ESCC cells. Meanwhile, we also found that overexpression of SCARA5 caused changes in mitochondrial morphology, accumulation of intracellular reactive oxygen species and increased intracellular Fe2+ in ESCC cells, which induced ferroptosis in ESCC cells. Mechanically, we validated that SCARA5 combined with ferritin light chain and increased intracellular Fe2+. As well as, overexpression SCARA5 induced ferroptosis by increasing ferritin light chain in nude mice subcutaneous tumors and inhibited the growth of nude mice subcutaneous tumors. Conclusion Collectively, our findings demonstrated that SCARA5 suppressed the proliferation and metastasis of ESCC by triggering ferroptosis through combining with ferritin light chain.

Fucoxanthin ameliorates traumatic brain injury by suppressing the blood–brain barrier disruption

“…The typical morphological changes of ferroptosis includes a decrease in mitochondrial volume and mitochondrial cristae, and an increase in mitochondrial membrane density. 48 Moreover, ferroptosis can be regulated by ACSL4 and GPX4. ACSL4 is an enzyme that facilitates free polyunsaturated fatty acids (PUFAs) to synthesize PUFA-phosphatidylethanolamines, which are unstable and prone to LPO.…”

Ferroptosis Involved in Cardiovascular Diseases: Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes

“…92 Studies have shown that scavenger receptor protein 5 (SCARA5), located on chromosome 8p21, can increase intracellular ROS and Fe 2+ accumulation by binding to the light chain of ferritin, thus inducing ferroptosis and inhibiting the proliferation and metastasis of esophageal squamous cell carcinoma cells. 93 These recent research advances highlight the clinical therapeutic potential of ferroptosis in CVDs and potential therapeutic strategies.…”

Mechanisms of esophageal cancer metastasis and treatment progress

“…It’s interesting to note that ferroptosis has two sides in tumor growth, necessitating careful target selection. Recently, it was found that DNAJB6 ( 186 ) and SCARA5 ( 187 ) can promote the process of ferroptosis in tumor cells and inhibit tumor progression.…”